RGL-193
/ Shanghai Regenelead Therapies
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 15, 2024
A Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's Disease
(clinicaltrials.gov)
- P1 | N=8 | Recruiting | Sponsor: Second Affiliated Hospital of Soochow University | Not yet recruiting ➔ Recruiting
Enrollment open • Metastases • CNS Disorders • Movement Disorders • Parkinson's Disease
January 08, 2024
A Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's Disease
(clinicaltrials.gov)
- P1 | N=8 | Not yet recruiting | Sponsor: Second Affiliated Hospital of Soochow University
Metastases • New P1 trial • CNS Disorders • Movement Disorders • Parkinson's Disease
1 to 2
Of
2
Go to page
1